NASDAQ: AIDX20/20 Biolabs Inc Stock Ownership - Who owns 20/20 Biolabs?
Insider buying vs selling
Have 20/20 Biolabs Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when AIDX insiders and whales buy or sell their stock.
AIDX Shareholders
What type of owners hold 20/20 Biolabs Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Jonathan M. Cohen | 12.88% | 1,366,400 | $1.65M | Insider |
| Cresset Asset Management LLC | 2.49% | 264,368 | $318.56k | Institution |
| Citadel Advisors LLC | 0.15% | 16,227 | $19.55k | Institution |
| John G. Compton | 0.14% | 14,335 | $17.27k | Insider |
| John Woodson Rollins | 0.10% | 11,111 | $13.39k | Insider |
| Xtx Topco Ltd | 0.10% | 10,329 | $12.45k | Institution |
| Ubs Group Ag | 0.08% | 8,314 | $10.02k | Institution |
| Richard M. Cohen | 0.07% | 7,700 | $9.28k | Insider |
| Mai Capital Management | 0.01% | 1,000 | $1.21k | Institution |
| Toth Financial Advisory Corp | 0.00% | 157 | $189.19 | Institution |
AIDX vs Medical Device Stocks
20/20 Biolabs Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.